How CHF Patients can Take Advantage of Translational Research?

You should be able to find several indispensable facts about congestive heart in the following paragraphs. If there's at least one fact you didn't know before, imagine the difference it might make.

In nature every action spawns a separate and equal reaction. In the field of medicine, the reaction may not always be equal to the action. The performance of a particular treatment in the lab on test animals may not be the same as would be seen in a human subject; this is where the field of translational research comes in.

Translational research takes research from the laboratory to the patient's bedside. This can be done in several forms. In its earliest stages a treatment will undergo controlled clinical trials with a voluntary group of test subjects. If these small, controlled tests meet the acceptable range of success the treatment is then taken to research hospitals such as St. Jude's or Children's Hospital of Boston. Here patients are given the opportunity to experience new methods of control and treatment of a disease with the understanding that it is still considered highly experimental; however, for many these treatments represent a chance for a cure that previously as out of reach for them as the moon.

Congestive heart failure is, at the moment, an incurable event, occurring when for whatever reason the cells of the heart muscle are destroyed and the heart can no longer adequately pump blood throughout the body. Once the cells in the heart tissue are non-functional the body is unable to replace them, making it impossible for the heart to regain full heart function on its own. The current mortality rate is high, and over fifty percent of patients with congestive heart failure will die within five years of being diagnosed. There are many treatment options currently being considered for congestive heart failure, however, and a number of new technologies being tested daily. For example, Montefiore Medical Center in New York City is currently doing clinical trials on a drug known as Lovosimendan, a calcium sensitizer that does not trigger cardiac arrhythmia, and research into the possibility of using stem cells to regrow cardiac tissue is ongoing.

You may not consider everything you just read to be crucial information about congestive heart. But don't be surprised if you find yourself recalling and using this very information in the next few days.

For a patient to take advantage of these options they should discuss the possibility of being a subject for clinical testing with their physician to see if they would be a good candidate, then allow the physician to make a recommendation on a course of action from there. It may be suggested that the patient contact a research facility, or the physician may suggest their name for a clinical trial they know is occurring soon. If the patient lives in an area with a research hospital nearby, chances are there will be an opportunity for them to benefit from the hospital's policy on translational research.

It should be understood that translational research is precisely what it sounds like; research. Scientists and doctors are often still learning about the treatment and its effect on the human body, and there is always a possibility that it will be unsuccessful or carry with it many hazardous side effects. These courses of treatments are unknowns to physician and researcher alike. For patients who have run out of options, however, even the possibility of a negative effect cannot stifle what the opportunity to be part of a translational research project provides: hope.

That's the latest from the congestive heart authorities. Once you're familiar with these ideas, you'll be ready to move to the next level.

My Articles

Why Is Peer Review Important In The Publication Of Medical Research? When seeking information on the latest updates in the..

What Evidence Of Congestive Heart Failure Is A Diagnosis Based On? While all cardiac conditions carry similar symptoms of chest..

How Can Continuing Medical Education Credits Be Obtained? While physicians spend many, many years in school prior to..

Epidemiology Epidemiology is the process of where one is able to study a disease or..

Related Videos:

Diabetes patients sue GSK: Lawsuit claims company suppressed data ...
Trading Markets (press release), CA - 16 hours ago
But the heart attack risk wasnot mentioned in Avandia's packaging information until November. The FDA raised existing warnings about congestive heart ...

Studies Equivocal on Value of Prayer - RedOrbit

Studies Equivocal on Value of Prayer
RedOrbit, TX - 19 hours ago
By Dr Manoj Jain My patient is an elderly man with end-stage congestive heart failure, kidney failure and now an infected dialysis line, and he is unlikely ...